Novel α-2-macroglobulin cleaved fragments as biomarkers of early liver fibrosis in patients with chronic hepatitis C

被引：0
|
作者：
Batxelli-Molina, Isabelle [1 ]
Calvayrac-Pawlowski, Sophie [1 ]
Moulin, Veronique [1 ]
Lapalus, Martine [2 ,3 ]
Hem, Sonia [4 ]
Laune, Daniel [1 ]
Asselah, Tarik [2 ,3 ]
Jardin-Watelet, Benedicte [1 ]
机构：
[1] SysDiag UMR 3145 CNRS Biorad, Montpellier, France
[2] Univ Paris Diderot, Hop Beaujon, Serv Hepatol, Clichy, France
[3] Univ Paris Diderot, Hop Beaujon, CRB3, INSERM,U773, Clichy, France
[4] INRA, UR1199, Lab Prote Fonct, F-34060 Montpellier, France
来源：
FUTURE VIROLOGY | 2015年 / 10卷 / 01期
关键词：
40 kDa isoforms; -2; macroglobulin; chronic hepatitis C; early diagnosis; liver fibrosis; serum; BIOCHEMICAL MARKERS; COST-EFFECTIVENESS; DOMAIN-STRUCTURE; HCV; VIRUS; BINDING; SEQUENCE; PROTEIN; ALPHA(2)-MACROGLOBULIN; EXPRESSION;
D O I：
10.2217/fvl.14.98
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Aim: Liver biopsy is considered the gold standard for the diagnosis and staging of hepatic fibrosis in patients with chronic hepatitis C and is now progressively replaced by noninvasive procedures. We aimed at improving -2-macroglobulin diagnostic value for liver fibrosis by identifying new isoforms that may be specifically related to early stages of the pathology. Materials & methods: -2-Macroglobulin isoforms were characterized in serum samples from patients with chronic hepatitis C and mild (F1) to moderate (F2) fibrosis by proteomic methods. Results: New biological 40 kDa C-terminal -2-macroglobulin fragments were identified as potential biomarkers of early fibrosis (fold change = 1.55; p < 0.01). Conclusion: The serum concentration of -2-macroglobulin fragments allows a better differentiation of F1 and F2 fibrosis stages than total -2-macroglobulin isoforms.
引用
收藏
页码：5 / 16
页数：12
相关论文
共 50 条
  • [21] The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C
    Gokcan, Hale
    Kuzu, Ufuk Baris
    Oztas, Erkin
    Saygili, Fatih
    Oztuna, Derya
    Suna, Nuretdin
    Tenlik, Ilyas
    Akdogan, Meral
    Kacar, Sabite
    Kilic, Zeki Mesut Yalin
    Kayacetin, Ertugrul
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2016, 27 (02) : 156 - 164
  • [22] Impact of Helicobacter pylori infection on liver fibrosis in Egyptian patients with chronic hepatitis C
    Ragheb, Mustafa M.
    Awad, Mohamed M. E.
    Eldeen, Loaa A. Tag
    Dosoki, Tamer M.
    JOURNAL OF ADVANCED RESEARCH, 2012, 3 (03) : 287 - 293
  • [23] Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection
    Martin-Carbonero, L.
    de Ledinghen, V.
    Moreno, A.
    Maida, I.
    Foucher, J.
    Barreiro, P.
    Romero, M.
    Satta, G.
    Garcia-Samaniego, J.
    Gonzalez-Lahoz, J.
    Soriano, V.
    JOURNAL OF VIRAL HEPATITIS, 2009, 16 (11) : 790 - 795
  • [24] Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C
    Poynard, Thierry
    Moussalli, Joseph
    Munteanu, Mona
    Thabut, Dominique
    Lebray, Pascal
    Rudler, Marika
    Ngo, Yen
    Thibault, Vincent
    Mkada, Helmi
    Charlotte, Frederic
    Bismut, Francoise Imbert
    Deckmyn, Olivier
    Benhamou, Yves
    Valantin, Marc Antoine
    Ratziu, Vlad
    Katlama, Christine
    JOURNAL OF HEPATOLOGY, 2013, 59 (04) : 675 - 683
  • [25] Circulating microRNAs associated with liver fibrosis in chronic hepatitis C patients
    Cabral, B. C. A.
    Hoffmann, L.
    Bottaro, T.
    Costa, P. F.
    Ramos, A. L. A.
    Coelho, H. S. M.
    Villela-Nogueira, C. A.
    Urmenyi, T. P.
    Faffe, D. S.
    Silva, R.
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2020, 24
  • [26] Noninvasive Diagnosis of Liver Fibrosis and Cirrhosis in Chronic Hepatitis C Patients
    Attallah, Abdelfattah M.
    El-Far, Mohamed
    Omran, Mohamed M.
    Farid, Khaled
    Albannan, Mohamed S.
    El-Dosoky, Ibrahim
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2013, 27 (02) : 121 - 129
  • [27] Liver fibrosis evaluation by ARFI and APRI in chronic hepatitis C
    Su-Mei Li
    Guang-Xia Li
    Dong-Mei Fu
    Yu Wang
    Li-Qun Dang
    World Journal of Gastroenterology, 2014, 20 (28) : 9528 - 9533
  • [28] Liver fibrosis evaluation by ARFI and APRI in chronic hepatitis C
    Li, Su-Mei
    Li, Guang-Xia
    Fu, Dong-Mei
    Wang, Yu
    Dang, Li-Qun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (28) : 9528 - 9533
  • [29] Early changes in dynamic biomarkers of liver fibrosis in hepatitis C virus-infected patients treated with sofosbuvir
    Bernuth, Sebastian
    Yagmur, Eray
    Schuppan, Detlef
    Sprinzl, Martin F.
    Zimmermann, Anca
    Schad, Arno
    Kittner, Jens M.
    Weyer, Veronika
    Knapstein, Johanna
    Schattenberg, Joern M.
    Woerns, Marcus A.
    Galle, Peter R.
    Zimmermann, Tim
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (03) : 291 - 297
  • [30] Histological factors that predict the liver fibrosis in patients with chronic hepatitis C
    Petrescu, Ileana Octavia
    Biciusca, Viorel
    Taisescu, Citto Iulian
    Alexandru, Dragos Ovidiu
    Taisescu, Oana
    Comanescu, Maria Victoria
    Petrescu, Florin
    Popescu, Iulian Alin Silviu
    Trasca, Diana-Maria
    Fortofoiu, Mircea Catalin
    Silosi, Cristian Adrian
    Fortofoiu, Maria
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2016, 57 (02) : 759 - 765
12345